Disclosure of Patentable Inventions. Each Party shall provide to the other Party any invention disclosure submitted in the normal course of its business which discloses a Collaboration Invention within [****] after the Party determines that an Invention has been made.
Disclosure of Patentable Inventions. In addition to the disclosures ----------------------------------- required under this Agreement, each party shall submit a written report to the other within sixty (60) days of the end of each quarter summarizing any invention arising during the prior quarter of the RESEARCH COLLABORATION in the FIELD which it believes may be patentable.
Disclosure of Patentable Inventions. In addition to the disclosures required, each Party shall provide the other any invention disclosure related to the Research Program which has been submitted to it in the normal course of disclosing an invention. Such invention disclosures shall be provided promptly after submission and in no event later than 10 business days after the end of the calendar quarter in which the disclosure was submitted.
Disclosure of Patentable Inventions. In addition to ----------------------------------- the disclosures required under Article XIII, each Party shall provide to the other any invention disclosure submitted in the normal course and disclosing an invention within the Field arising in the course of the collaboration during the term of this Agreement. Such invention disclosures shall be provided to the other Party promptly after submission and in no event later than ten (10) days after the end of the calendar quarter in which the disclosure was submitted.
Disclosure of Patentable Inventions. Each Party shall provide to the other any patent application disclosing an invention relating to Licensed Products within the Field arising during the term of this Agreement. Such patent applications disclosing inventions made solely by a Party shall be provided to the other Party promptly after submission of such application to a governmental Patent authority, which shall in no event be later than [*] days after the date the disclosure was submitted. Any such patent applications disclosing inventions made jointly by the Parties shall be provided by BioSearch to IntraBiotics reasonably in advance of the intended date for submission of such application to a governmental Patent authority. [ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.
Disclosure of Patentable Inventions. Each Party shall provide to the other any invention disclosure submitted in the normal course of performing its obligations hereunder which discloses an invention related to the Enoximone in the Field or the Products. Such invention disclosures shall be provided to the other Party promptly after submission and in no event later than ten (10) days after the end of the calendar quarter in which the disclosure was submitted, provided, however, that no disclosure is required that would constitute publication prior to the time a patent issues, and in any case all submissions will be considered Confidential Information of the Party submitting the invention disclosure.
Disclosure of Patentable Inventions. Each Party shall promptly, but no later than thirty days after such Party determines that an invention has been made, disclose to the other Party any Collaboration Inventions. In the event patent applications or patents are not filed on such invention disclosures by either Party, such inventions shall be considered Know-How hereunder.
Disclosure of Patentable Inventions. In addition to the disclosures required under Article 13 below, each Party shall provide to the other Party any invention disclosure submitted in the normal course of its business which discloses a Collaboration Invention. Such invention disclosures shall be provided to the other Party within thirty (30) days after the Party determines that an invention has been made. In the event patent applications are not filed on such invention disclosures by either Party, such invention disclosures shall be considered Know-how hereunder.
Disclosure of Patentable Inventions. 20 6.3 Access to Gene Patent Rights........................................................................ 21
Disclosure of Patentable Inventions. In addition to the disclosures required under Sections 2.6 and 7.3, each Party shall submit a written report to the other Parties within [ * ] after the end of each quarter describing any invention arising during the prior quarter in the course of the Research done during the Research Term which it believes may be patentable. The LLC and Exelixis shall provide Bayer with drafts of any patent application which discloses an LLC Assay or Target prior to filing, allowing adequate time for review and comment by Bayer if possible; provided, however, that the LLC and/or Exelixis shall not delay the filing of any patent application pursuant to Section 10.3 below. [*]=CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.
